Literature DB >> 22555849

Predicting outcome of depression using the depressive symptom profile: the Leiden Routine Outcome Monitoring Study.

Martijn S van Noorden1, Esther M van Fenema, Nic J A van der Wee, Frans G Zitman, Erik J Giltay.   

Abstract

BACKGROUND: To investigate the predictive value of items for individual depressive symptoms measured with the self-rated Beck Depression Inventory-Revised (BDI-II) self-report scale on outcome in a large naturalistic cohort of depressive outpatients.
METHODS: We used a cohort of 1,489 adult patients aged 18-65 years with major depressive disorder or dysthymic disorder established with the MINI-Plus diagnostic interview. All patients had a routine outcome monitoring baseline measurement in 2004-2009, with a maximum of 2 years follow-up. We used multivariable Cox regression models to predict remission (MADRS < 10; where MADRS stands for Montgomery-Åsberg Depression Rating Scale) and response (≥50% improvement), and adjusted for clinical and demographic characteristics (i.e. marital status, level of education, working status, comorbid anxiety, avoidant and borderline personality traits, and suicidality) that were identified as predictors in earlier studies.
RESULTS: Of the 21 BDI-II items, the items "pessimism" and "loss of energy" independently predicted for both remission and response. For pessimism, the hazard ratio (HR) for remission was 0.81 (95% confidence interval [CI]: 0.73-0.89, P < .001) and for loss of energy, the HR was 0.81 (95% CI: 0.72-0.92, P = .001).
CONCLUSIONS: These findings of robust prediction of poor outcome by baseline items of "pessimism" and "loss of energy" in a naturalistic treatment setting may help clinicians to identify depressive patients in need for additional or alternative therapeutic approaches.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22555849     DOI: 10.1002/da.21958

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  8 in total

Review 1.  The epidemiology of sleep and obesity.

Authors:  Rachel P Ogilvie; Sanjay R Patel
Journal:  Sleep Health       Date:  2017-08-15

2.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

3.  Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.

Authors:  Mitsuhiro Tada; Hiroyuki Uchida; Takefumi Suzuki; Takayuki Abe; Bruce G Pollock; Masaru Mimura
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

4.  Longitudinal Association of Sleep Duration with Depressive Symptoms among Middle-aged and Older Chinese.

Authors:  Yujie Li; Yili Wu; Long Zhai; Tong Wang; Yongye Sun; Dongfeng Zhang
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

5.  Predictors of response in the treatment of moderate depression.

Authors:  Andre G Bastos; Luciano S Guimarães; Clarissa M Trentini
Journal:  Braz J Psychiatry       Date:  2016-11-24       Impact factor: 2.697

6.  Testing for response shift in treatment evaluation of change in self-reported psychopathology amongst secondary psychiatric care outpatients.

Authors:  Ingrid V E Carlier; Wessel A van Eeden; Kim de Jong; Erik J Giltay; Martijn S van Noorden; Christina van der Feltz-Cornelis; Frans G Zitman; Henk Kelderman; Albert M van Hemert
Journal:  Int J Methods Psychiatr Res       Date:  2019-06-17       Impact factor: 4.035

7.  Factors affecting the evolution of Chinese elderly depression: a cross-sectional study.

Authors:  Longyan Cui; Ding Ding; Junfeng Chen; Minghui Wang; Fanrong He; Shiyang Yu
Journal:  BMC Geriatr       Date:  2022-02-08       Impact factor: 3.921

8.  Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Authors:  Sarah Gerasch; Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Front Neurosci       Date:  2016-09-12       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.